Taken together, the development of an early onset and aggressive tumor phenotype in Cdh1L/L:PtenL/L:PB-Cre4 compound mice in comparison with PtenL/L:PB-Cre4 mice demonstrates a promotional role of E-cadherin deletion in prostate tumor formation and progression. Here, CDH1 is linked to prostate neoplasm.